Rachael O. Oyewole

FDA investigator

Appears on 10 documents from 2020 to 2023, most often at sites in Pennsylvania. Most often cites production record review (21 CFR 211.192).

10
Documents on file
5.5
Observations per 483
2020
First seen
2023
Most recent

What they cite most

From 55 observations

Activity by year

2020: 2, 2021: 2, 2022: 3, 2023: 3

Where

Pennsylvania 4 · India 2 · New Jersey 2 · Maryland 1 · New York 1

Is Rachael O. Oyewole coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

10 documents, newest first
FirmOpen
483 K PATEL PHYTO EXTRACTIONS PRIVATE LIMITEDApr 28, 2023 · Valsad, India
483 MSN Pharmachem Private LimitedApr 21, 2023 · Patancheru (Mandal), India
483 Veranova, L.P.Feb 15, 2023 · West Deptford, New Jersey
483 Pharmaceutics International, Inc.Nov 14, 2022 · Cockeysville, Maryland
483 Renu Laboratories, LLCJul 27, 2022 · Warminster, Pennsylvania
483 Premier Brands of America IncMay 16, 2022 · Orangeburg, New York
483 Teligent, Inc.Aug 31, 2021 · Buena, New Jersey

About this profile

What does Rachael O. Oyewole inspect?

Rachael O. Oyewole appears on 10 documents on file covering 10 sites, most often in Pennsylvania.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.22 and 21 CFR 211.67.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Rachael O. Oyewole is dated Apr 28, 2023.